When children experience regular snoring but show only mild breathing disturbances in sleep studies, parents and doctors often grapple with whether to proceed with surgery or adopt a wait-and-see approach. A recent analysis from the Pediatric Adenotonsillectomy Trial for Snoring (PATS) provides insights into the outcomes of this decision. Published in the Journal of Clinical Sleep Medicine, the study found discrepancies between sleep lab results and home experiences for families, with over half of the children in the watchful waiting group continuing to exhibit significant symptoms despite only a small number showing objective declines in sleep study results after one year.
Read More
The research utilized data from 234 children, ages 3 to 12.9, who were part of the control group of PATS, which ran from 2016 to 2021 across seven U.S. referral centers. These children snored at least three nights per week and had an obstructive apnea-hypopnea index (oAHI) of fewer than three events per hour, along with enlarged tonsils. Participants were either assigned to early adenotonsillectomy or to the watchful waiting group, which received supportive care.
The study defined progression using two criteria: objective worsening in oAHI and a caregiver-reported Pediatric Sleep Questionnaire score indicating significant symptoms. Of the 150 children who completed the follow-up sleep studies, only 20 (13 percent) progressed to an oAHI of three or greater over 12 months. Most children’s airway functions either remained stable or improved, aligning with previous findings that approximately 40 percent of children with mild obstructive sleep apnea improve without intervention within a year.
However, the study showed that symptom persistence was a concern. Among the 192 children with follow-up symptom data, 110 (57 percent) reported a high symptom burden at the one-year mark. Most of these cases were from children who had experienced elevated symptom levels from the outset, rather than new cases emerging. Notably, 80 percent of children whose symptoms persisted did not show corresponding changes in sleep study results, highlighting a disconnect between clinical metrics and real-world symptomatology.
Certain factors were identified as predictors of worsening conditions. For instance, Black children were more than twice as likely to experience objective sleep study progression, and higher baseline symptom scores increased the odds of such progression significantly. Asthma and ADHD were also found to be associated with increased chances of symptom persistence. In a surprising finding, children with larger tonsils had lower odds of ongoing symptomatic issues, suggesting that their condition might be less variable during observation compared to those with smaller tonsil sizes.
The implications of the study suggest that while a repeat sleep study can identify a minority of children whose conditions worsen, it may overlook a larger group whose quality of life and symptoms remain impaired even with mild apnea indices. The authors recommend careful symptom assessment over time and suggest that children with certain risk factors may benefit from earlier surgical intervention. This analysis reframes the concept of watchful waiting as a strategy requiring careful monitoring rather than a passive approach, setting the groundwork for future studies to identify which children might benefit most from immediate surgery versus those suitable for observation.